United States· US:17156-210_900b7272-7f13-43ef-9320-bc63ccc1434b

DaTscan

A medicinal product containing ioflupane i-123, registered in United States by Medi-Physics Inc. dba GE Healthcare..

US label

Checked against FDA National Drug Code directory (United States) on September 27, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about ioflupane i-123Answers with sources · free account Check interactionsSeverity free · mechanism on Growth

The record

At a glance

FDA National Drug Code directory (United States)

Active substance: IOFLUPANE I-123
Manufacturer: Medi-Physics Inc. dba GE Healthcare.
Country: United States (US)
ATC code: —
Reimbursed: Not published by this register
Source register: FDA National Drug Code directory (United States)
Last checked: September 27, 2026

Packs & prices · 2

ndc11
1715621001
1 VIAL, GLASS in 1 CONTAINER (17156-210-01) / 2.5 mL in 1 VIAL, GLASS
ndc11
17156-210-01

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Ioflupane i-123 in 9 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All ioflupane i-123 products

Authorised across Europe · EMA

The same active substance is authorised in 16 EEA countries. Names it is sold under:

Austria · Ioflupan (123i) Rotop
Belgium · Ioflupan (123i) Rotop, Ioflupane (123i) Rotop
Czechia · Joflupan (123i) Rotop
Germany · Ioflupan (123i) Rotop
Finland · Joflupaani (123i) Rotop
France · Ioflupane (123i) Rotop
United Kingdom (Northern Ireland) · Datscan, Ioflupane (123i) Rotop
Iceland · Datscan, Striascan
Italy · Ioflupane (123i) Rotop
Liechtenstein · Datscan
Luxembourg · Ioflupane (123i) Rotop
Netherlands · Joflupaan (123i) Rotop
Norway · Datscan, Ioflupane (123i) Rotop
Poland · Ioflupane (123i) Rotop
Portugal · Ioflupano (123i) Rotop
Sweden · Ioflupan (123i) Rotop

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/2956f874-3d14-4485-8c98-3e26a0b74980
GET /v1/drugs/2956f874-3d14-4485-8c98-3e26a0b74980?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "INTRAVENOUS",
  "source": "ndc",
  "strength": "2",
  "substance": "IOFLUPANE I-123",
  "productndc": "17156-210",
  "dosage_form": "INJECTION, SOLUTION",
  "dea_schedule": null,
  "strength_unit": "mCi/mL",
  "application_number": "NDA022454",
  "marketing_category": "NDA"
}

API reference MCP server Plans

See everything about ioflupane i-123.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console